Report Highlights
The global market for intravenous (IV) therapy and vein access is expected to grow from $49.5 billion in 2026 and is projected to reach $67.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2026 to 2031.
Report Includes
- 77 data tables and 68 additional tables
- Overview of the global intravenous (IV) therapy and vein access market
- Analyses of global market trends, with revenue data for 2023-2025, estimates for 2026, and projections of CAGRs through 2031
- Evaluation of the market by product type, application, and region
- Discussion of major market drivers, restraints, challenges, and opportunities shaping the adoption of IV therapy and vein access technologies worldwide
- Review of regulatory frameworks in key countries, along with analysis of macroeconomic factors, Porter’s Five Forces, and the impact of U.S. tariffs on the industry
- Regional market coverage North America, Europe, Asia-Pacific, the Middle East & Africa, and South America
- Profiles of leading companies and emerging startups, highlighting their product offerings, business strategies, and recent developments, including BD, Fresenius SE & Co. KGaA, Baxter, B. Braun SE, and Insulet Corp.
Report Scope
This report examines the global IV therapy and vein access device market, providing a comprehensive review of applications across various healthcare facility settings.
The study covers a range of IV solutions and devices used in therapeutic applications. BCC Research has analyzed critical market components, including types of intravenous solutions. The report includes segments by product type and application. By product type, the market is segmented into IV solutions and sets, infusion pumps and accessories, and vein access devices (IV catheters). IV solutions and sets are categorized into general IV solutions, parenteral nutrition IV solutions, premixed drug IV solutions, and other IV solutions and sets. Infusion pumps and accessories include general infusion pumps, specialized infusion pumps, and other infusion accessories. Vein access devices cover peripheral intravenous catheters and central venous catheters.
Product inclusions for each IV solution and sets market segment:
- General IV solutions: Includes normal saline, hypertonic saline, Lactated Ringer’s, Dextran, and dextrose in water used for hydration, fluid replacement, and electrolyte management.
- Parenteral nutrition IV solutions: Includes intravenous nutritional formulations containing carbohydrates, lipid emulsions, amino acids, vitamins, minerals, and trace elements.
- Premixed IV solutions: Includes ready-to-administer premixed IV drugs such as antibiotics, pain-management medications, and cardiovascular agents, supplied in IV bags, bottles, or other containers.
- Other IV solutions and sets: Includes specialized IV solutions not covered above, along with administration sets, extension sets, connectors, filters, and other IV delivery accessories.
This report addresses regulatory aspects, including innovations, technological advances (patents and approvals), and the latest trends, preferences, and developments in IV therapy. It also includes market projections, key companies, and market share analysis for the global IV therapy and vein access market. The scope also includes emerging technologies, such as advanced intraosseous infusion systems, antimicrobial-coated sets, needleless connectors, and smart vein visualization and vascular-access devices, which are expected to improve the safety, efficiency, and reliability of vascular-access procedures. The market has been segmented into major regions, including North America, Asia-Pacific, Europe, and the rest of the world (RoW). The analysis covers countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea, and China.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2025 | ||||||||||||||||
| Forecast period considered | 2026-2031 | ||||||||||||||||
| Base year market size | $46.7 Billion | ||||||||||||||||
| Market size forecast | $67.6 Billion | ||||||||||||||||
| Growth rate | CAGR of 6.4% for the forecast period of 2026-2031 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Product Type, Application, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Australia, South America, and Middle East and Africa | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
- Increasing burden of chronic diseases requiring long-term infusion therapy.
- Growing surgical procedures and hospital admissions are driving vascular access demand.
- Rapid expansion of home infusion therapy.
- Stronger infection prevention guidelines are accelerating the adoption of advanced vein access technologies.
- Risk of infections and complications.
- Regulatory challenges in the intravenous therapy and vein access market.
- Safety and recall challenges in intravenous therapy.
- Technological advancements.
- Expanding pipeline of infusion-based biologics and specialty therapies.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Clinical Nutrition: Global Markets to 2031
The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.
Global Markets for Catheters
The global market for catheters is expected to grow from $22.8 billion in 2025 and is projected to reach $36 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.
Anesthesia and Respiratory Devices: Global Markets
The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for intravenous (IV) therapy and vein access is expected to grow from $49.5 billion in 2026 and is projected to reach $67.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2026 to 2031.
Liquid Biopsy with Emphasis on Cancer: Global Markets
The global market for liquid biopsy with emphasis on cancer is expected to grow from $4.1 billion in 2026 and is projected to reach $8 billion by the end of 2031, at a compound annual growth rate (CAGR) of 14.1% during the forecast period of 2026 to 2031.
Global Pathology Services Market
The global market for pathology services was valued at $225 billion in 2025 and, is estimated to reach $307.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.5% from 2025 through 2030.
Global Markets and Technologies for Electronic Health Records
The global market for electronic health records is expected to grow from $36.5 billion in 2025 and is projected to reach $52.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.4% during the forecast period of 2025 to 2030.
Global Cognitive Computing and Artificial Intelligence Systems Market in Healthcare
The global market for cognitive computing and Artificial Intelligence (AI) systems market in healthcare was valued at $11.4 billion in 2025 and, is estimated to reach $50.1 billion by 2030, at a compound annual growth rate (CAGR) of 34.4% from 2025 through 2030.
Top Trending Reports
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Outpatient Surgical Procedures: Global Markets
The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.
Global Markets for Fermentation Ingredients
The global market for fermentation ingredients is expected to grow from $39.8 billion in 2026 and is projected to reach $53.4 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2026 to 2031.
Global Enterprise Artificial Intelligence (AI) Market
This study examines the global enterprise AI market across key segments such as component, software deployment, technology, organization size, end user and geography. It focuses on commercially deployed AI software, services and hardware generating revenue across industries, including new deployments and the expansion of existing AI infrastructure. The analysis also covers emerging technologies, major market trends and challenges, the competitive landscape and profiles of leading companies. Regional market trends are assessed using 2025 as the base year, with forecasts from 2026 through 2031.
The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
The U.S. market for biodefense-related rapid pathogen identification and treatments is expected to grow from $8.4 billion in 2026 and is projected to reach $12.1 billion by the end of 2031, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2026 to 2031.
Report Highlights
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Report Includes
- 92 data tables and 53 additional tables
- Analyses of the global market trends for intravenous (IV) therapy and venous access devices, with revenue data from 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type, application, end user and region
- Discussion of the market potential and opportunities in the medical device industry, along with an analysis of the competitive environment, regulatory scenario, and technological advances
- Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors
- Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Patent analysis featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Company profiles, including Becton, Dickinson (BD), B. Braun, Fresenius SE & Co. KGaA, Baxter and Medtronic
Report Highlights
The global market for IV therapy and vein access will grow from nearly $40.7 billion in 2018 to $54.5 billion by 2023 with a compound annual growth rate (CAGR) of 6.0% for the period of 2018-2023.
Report Includes
- 98 data tables and 43 additional tables
- An overview of global markets for the intravenous (IV) therapy and vein access within the industry
- Analyses of global market trends with data from 2017,2018, and projections of compound annual growth rates (CAGRs) through 2023
- Encompassing details of different types of IV solutions and devices used for therapeutic purposes
- Coverage of the associated regulatory aspects such as innovations and technological improvements (patents and approvals), latest trends, preferences and progress in the field of IV therapy
- Detailed information on the main categories for IV therapy, including ambulatory infusion pumps, central venous access devices, diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps
- Examination of the vendor landscape and market shares of leading global players
- Profiles of the companies related to the industry, including B. Braun Melsungen, Fresenius Kabi; Medtronic, Teleflex, Insulet Corp., Tandem Diabetes Care and Nestle Health Science
Report Highlights
The global intravenous (IV) therapy and vein access market should reach $29 billion by 2021 from $21.6 billion in 2016 at a compound annual growth rate (CAGR) of 6.1%, from 2016 to 2021.
Report Includes
- An overview of the global markets and technologies for intravenous (IV) therapy and vein access.
- Analyses of market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Detailed information on the main categories for IV therapy, including ambulatory infusion pumps, central venous access devices, diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps.
- Identification of current products on the market.
- Assessments of the competitive landscape and competitor market shares.
- Profiles of the company related to the industry.
Report Highlights
The global market for intravenous therapy and vein access was $19.3 billion in 2013. The market reached $20.3 billion in 2014 and is expected to reach about $27.2 billion in 2019, registering a compound annual growth (CAGR) of 6.0% over the next five years.
Report Includes
- An overview of the global markets and technologies for intravenous (IV) therapy and vein access.
- Analyses of market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Detailed information on the main categories for IV therapy including ambulatory infusion pumps, central venous access devices, Diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps.
- Identification of current products on the market.
- Assessments of the competitive landscape and competitor market shares.
Report Highlights
- In 2009, the total global intravenous therapy and vein access market reached nearly; $8.8 billion and is forecast to reach $11.2 billion in 2014, a compound annual growth rate (CAGR) of 5%.
- Insulin-infusion pumps are expected to show the greatest demand over the forecast period. This segment was worth $1.1 billion in 2009 and is expected to increase at an 8.1% compound annual growth rate (CAGR) to reach $1.6 billion in 2014.
- The central venous access devices and implantable pumps segment will experience a 5.7% compound annual growth rate (CAGR) over the forecast period. This market was valued at $975 million in 2009 and is expected to reach a value of nearly $1.3 billion in 2014.
Report Highlights
-
U.S. market revenues for IV therapy and vein access were worth more than $4.6 billion in 2005. At an average annual growth rate (AAGR) of 4.2%, the market will reach almost $5.7 billion by 2010.
-
The market is broken down by ambulatory infusion pumps, enteral feeding pumps, peripheral venous access devices, and syringe infusion pumps. Ambulatory fusion pumps and peripheral venous access devices both held approximately 30% of the market share in 2005. Fusion pumps will maintain the majority of the market through the forecast period, holding a 29% share in 2010.
-
The fastest growing market sector will be syringe infusion pumps, which will have an AAGR of approximately 6.8% through the forecast period.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More